Ratify Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ratify Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ratify Trial Today - Breaking & Trending Today

Quizartinib May Represent an Additional Therapeutic Option for FLT3-ITD+ AML

Published: April 3, 2023

Mark Levis, MD, PhD, discusses potential changes to the FLT3-ITD-mutated acute myeloid leukemia treatment landscape that may occur if the FDA approves quizartinib, key efficacy and safety data with the agent, and how quizartinib compares with midostaurin.

Source: onclive.com

Related Topics:

United StatesMark LevisHematologic MalignanciesBone Marrow Transplant ProgramFlt3 Itd Mutated Acute Myeloid Leukemia Treatment Landscape Fda Approves QuizartinibHow Quizartinib Compares With MidostaurinQuantumr Randomized Data Ratify Trial